Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,841 to 1,860 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings. | Int J Mol Sci | 2020 | 32414002 | PubTator, text mining | PubMed |
| Methodology for the identification of small molecule inhibitors of the Fanconi Anaemia ubiquitin E3 ligase complex. | Sci Rep | 2020 | 32409752 | PubTator, text mining | PubMed |
| Novel tumor mutation score versus tumor mutation burden in predicting survival after immunotherapy in pan-cancer patients from the MSK-IMPACT cohort. | Ann Transl Med | 2020 | 32395490 | PubTator, text mining | PubMed |
| Hematopoietic Stem Cell Transplantation in Egypt: Challenges and Opportunities. | Mediterr J Hematol Infect Dis | 2020 | 32395212 | PubTator, text mining | PubMed |
| Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies. | J Immunother Cancer | 2020 | 32393474 | PubTator, text mining | PubMed |
| The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis. | Cancers (Basel) | 2020 | 32392735 | PubTator, text mining | PubMed |
| Drug Targeting of Genomic Instability in Multiple Myeloma. | Front Genet | 2020 | 32373151 | PubTator, text mining | PubMed |
| Risk Assessment Considerations for Genetically Modified RNAi Plants: EFSA's Activities and Perspective. | Front Plant Sci | 2020 | 32373145 | PubTator, text mining | PubMed |
| Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform. | Oncologist | 2020 | 32369643 | PubTator, text mining | PubMed |
| BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects. | Cancer Manag Res | 2020 | 32368150 | PubTator, text mining | PubMed |
| Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients. | Diagnostics (Basel) | 2020 | 32365798 | PubTator, text mining | PubMed |
| Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma. | Cancer Cell | 2020 | 32359397 | PubTator, text mining | PubMed |
| Precise control of the interlayer twist angle in large scale MoS2 homostructures. | Nat Commun | 2020 | 32358571 | PubTator, text mining | PubMed |
| Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links. | Genes Dev | 2020 | 32354836 | PubTator, text mining | PubMed |
| Cracking the Monoubiquitin Code of Genetic Diseases. | Int J Mol Sci | 2020 | 32344852 | PubTator, text mining | PubMed |
| Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study. | BMJ Open Gastroenterol | 2020 | 32337054 | PubTator, text mining | PubMed |
| Clinical and epidemiological features of COVID-19 family clusters in Beijing, China. | J Infect | 2020 | 32335171 | PubTator, text mining | PubMed |
| TALEN mediated gene editing in a mouse model of Fanconi anemia. | Sci Rep | 2020 | 32332829 | PubTator, text mining | PubMed |
| Next-Generation Sequencing-Based Cancer Panel Data Conversion Using International Standards to Implement a Clinical Next-Generation Sequencing Research System: Single-Institution Study. | JMIR Med Inform | 2020 | 32329738 | PubTator, text mining | PubMed |
| Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer. | Cancers (Basel) | 2020 | 32326341 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=93